C07D 319/18
Ethylenedioxybenzenes, not substituted on the hetero ring
C07D319/18 (Ethylenedioxybenzenes, not substituted on the hetero ring) appears on 637 US grants and 578 published applications in this corpus.
Search patents in C07D- Granted patents
- 637
- Published applications
- 578
- Assignees
- 374
- Inventors
- 2,229
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 6 | 0 |
| 1978 | 16 | 0 |
| 1979 | 5 | 0 |
| 1980 | 9 | 0 |
| 1981 | 7 | 0 |
| 1982 | 5 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 6 | 0 |
| 1986 | 3 | 0 |
| 1987 | 8 | 0 |
| 1988 | 6 | 0 |
| 1989 | 4 | 0 |
| 1990 | 6 | 0 |
| 1991 | 8 | 0 |
| 1992 | 7 | 0 |
| 1993 | 12 | 0 |
| 1994 | 8 | 0 |
| 1995 | 14 | 0 |
| 1996 | 14 | 0 |
| 1997 | 12 | 0 |
| 1998 | 20 | 0 |
| 1999 | 17 | 0 |
| 2000 | 16 | 0 |
| 2001 | 20 | 4 |
| 2002 | 15 | 22 |
| 2003 | 18 | 30 |
| 2004 | 19 | 31 |
| 2005 | 14 | 34 |
| 2006 | 19 | 36 |
| 2007 | 22 | 26 |
| 2008 | 21 | 25 |
| 2009 | 13 | 33 |
| 2010 | 14 | 36 |
| 2011 | 17 | 25 |
| 2012 | 15 | 22 |
| 2013 | 19 | 19 |
| 2014 | 27 | 30 |
| 2015 | 22 | 28 |
| 2016 | 23 | 21 |
| 2017 | 21 | 19 |
| 2018 | 17 | 10 |
| 2019 | 11 | 15 |
| 2020 | 8 | 20 |
| 2021 | 13 | 14 |
| 2022 | 8 | 13 |
| 2023 | 11 | 19 |
| 2024 | 9 | 20 |
| 2025 | 17 | 13 |
| 2026 | 4 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Benzylamine derivative, preparation method therefor and use thereof24 Mar 2026US 12,583,822 B2Academy of Military Medical Sciences
- 3-substituted phenylamidine compounds, preparation and use thereof10 Feb 2026US 12,545,639 B2Pi Industries Ltd.
- 3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same10 Feb 2026US 12,545,643 B2Amenis Bioscience, Inc.
- Benzamide derivatives as cGAS-sting pathway agonists30 Dec 2025US 12,509,436 B2Baruch S. Blumberg Institute
- Photochromic compound, propargyl alcohol compound, curable composition, optical article, lens, and spectacles24 Sep 2026US 2026/0286216 A1Tokuyama Corporation
- Methods and compositions for prevention of anaphylaxis20 Aug 2026US 2026/0242369 A1Baylor College of Medicine
- Therapeutic compounds and compositions13 Aug 2026US 2026/0234110 A1Agios Pharmaceuticals, Inc.
- Compounds with immunomodulatory activity and therapeutic uses thereof30 Jul 2026US 2026/0217665 A1Purdue Research Foundation
- Compounds for the treatment of neuromuscular disorders16 Jul 2026US 2026/0199369 A1Nmd Pharma A/S
Most cited
By later US patents
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Calcium receptor-active compounds114US 6,211,244 B1NPS Pharmaceuticals, Inc. · 2001
- Oxime derivatives and the use thereof as latent acids99US 6,261,738 B1Ciba Specialty Chemicals Corporation · 2001
- Amino acid derivatives, the process for their preparation and their applications to therapy85US 5,599,951 ASociete Civile Bioprojet · 1997
- N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase82US 6,660,756 B2Pfizer Inc. · 2003